CRISPR Therapeutics

49.51
+0.70
+1.43%
CRSP
高 49.95开 47.10量 172.79万股总市值 47.52亿
低 47.10换 1.80%额 8447.60万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
CRISPR Therapeutics(CRSP)
16小时前  
$CRISPR Therapeutics(CRSP)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-26-140224  Act: 34  Size: 13 MB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-25 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-122267  Size: 8 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-25 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-122274  Size: 13 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-25 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-122272  Size: 13 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-25 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-122268  Size: 13 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-18 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-111281  Size: 9 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-18 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-111278  Size: 9 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-18 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-111286  Size: 9 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-18 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-111284  Size: 16 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-17 04:15  
$CRISPR Therapeutics(CRSP)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001193125-26-108333  Act: 34  Size: 1 MB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-13 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-104480  Size: 9 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-13 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-104481  Size: 9 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
03-11 19:15  
$CRISPR Therapeutics(CRSP)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-26-101073  Act: 34  Size: 205 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
02-21 06:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-061710  Size: 8 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
02-21 06:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-061712  Size: 9 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
02-18 01:15  
$CRISPR Therapeutics(CRSP)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000940594-26-000006  Act: 34  Size: 10 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
02-13 06:05  
$CRISPR Therapeutics(CRSP)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-26-048957  Act: 34  Size: 24 MB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
02-13 05:48  
$CRISPR Therapeutics(CRSP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-26-048873  Act: 34  Size: 417 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
02-06 03:15  
$CRISPR Therapeutics(CRSP)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001562230-26-000001  Act: 34  Size: 7 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
01-28 06:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-024955  Size: 5 KB 网页链接